Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
News 13 Feb 2020 New laboratory adds much-needed capacity for mycetoma clinical research and treatment
News 30 Jan 2020 G-Finder Report: DNDi calls for increase in global R&D funding for NTDs on the first World NTD Day
News 27 Nov 2019 DNDi and partners hold seminar in Mexico aimed at improving access to diagnostics and treatment of Chagas disease
News 9 Oct 2019 DNDi welcomes GHIT support for a new collaboration with Mitsubishi Tanabe Pharma Corporation
News 15 Aug 2019 DNDi congratulates the TB Alliance for the FDA approval of a desperately-needed new treatment for drug-resistant forms of tuberculosis
News 26 Jun 2019 DNDi receives 1 billion yen from Takeda to improve access to treatment for neglected patients
